BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260530T170000
DTEND;TZID=Australia/Sydney:20260530T170000
DTSTAMP:20260610T084508
CREATED:20260331T013448Z
LAST-MODIFIED:20260331T013448Z
UID:10000274-1780160400-1780160400@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Clinical Investigator Awards
DESCRIPTION:Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90\,000. \nEligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position\, or have been in such a post for no more than 36 months on 1 May of the year of application. \nApplicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department\, a teaching hospital\, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account. \nKey Dates\nApplications open: 6 April 2026\nApplications close: 30 May 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/the-viertel-foundation-investigator-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/The-Viertel-Clinical-Investigator-Awards-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260603T170000
DTEND;TZID=Australia/Sydney:20260603T170000
DTSTAMP:20260610T084508
CREATED:20260331T013308Z
LAST-MODIFIED:20260331T013308Z
UID:10000275-1780506000-1780506000@melanoma.org.au
SUMMARY:NHMRC Postgraduate Scholarships
DESCRIPTION:The National Health and Medical Research Council (NHMRC) Postgraduate Scholarships scheme funds successful applicants to attain a research based postgraduate degree – Doctor of Philosophy (PhD) or a Research Masters Degree. \n\nIt aims to support these outstanding health and medical graduates early in their career so they can be trained to conduct research that is internationally competitive and develop a capacity for original independent research within Australia. \nThe intended outcome of the Postgraduate Scholarships scheme is increased research capacity within Australia. \nPostgraduate Scholarships may be funded by\, or in conjunction with\, other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations. \n\nKey Dates\nApplications open: 8 April 2026\nMinimum data due date: 13 May 2026\nApplications close: 3 June 2026\nProposed peer review: July/August 2026 \nThe Guidelines will be available here when the round opens. \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-postgrad-scholarships/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Postgraduate-Scholarships-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260604T170000
DTEND;TZID=Australia/Sydney:20260604T170000
DTSTAMP:20260610T084508
CREATED:20260505T054709Z
LAST-MODIFIED:20260505T054709Z
UID:10000289-1780592400-1780592400@melanoma.org.au
SUMMARY:SNOW MEDICAL Snow Fellowship
DESCRIPTION:Snow Fellowships target emerging global research leaders that show the potential to drive\, manage and influence the next generation of health and medical innovation. The Fellowship provides these emerging leaders the independence\, funding and time to develop a bold research program\, build their research team\, and establish leadership experience. \nEach Snow Fellowship will be valued at approximately $8 million over eight years for eligible early to mid-career researchers. Fellowship funding will be available to set up and operate a research laboratory\, comprising salaries for the Snow Fellow and post doctoral researchers\, PhD student scholarship top-ups\, technical and laboratory management support\, project funds and leadership development. \nThe Snow Fellowship program supports ambitious research and high-performing teams\, and we believe that these are based on diversity\, inclusivity and gender equality. \nSnow Fellowship \nBiomedical research\nUp to $1M per year\n8 years of funding (review at year 4/5)\nMentorship\, leadership and management training support \nKey Dates \nExpression of Interest closes: 4 June 2026\nFull Application opens (via invitation): 1st week of August 2026\nFull Application closes: 1 October 2026\nInterview: early February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/snow_medical/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/Snow-Fellowship-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260609T170000
DTEND;TZID=Australia/Sydney:20260609T170000
DTSTAMP:20260610T084508
CREATED:20260602T043120Z
LAST-MODIFIED:20260602T043120Z
UID:10000304-1781024400-1781024400@melanoma.org.au
SUMMARY:NSW Health Medical Devices Fund
DESCRIPTION:The Medical Devices Fund provides grants to drive the commercialisation of highly innovative new devices and technologies in NSW\, addressing gaps in the product life cycle between early-stage research and mature investment opportunities. \n\nThe Medical Devices Fund aims to: \n\n\n\nSupport individuals\, companies\, public and private hospitals\, medical research institutes\, universities\, other public sector research organisations\, and the medical devices industry\, to take local innovation to market\n\n\n\n\nIncrease the uptake of NSW medical devices that are cost effective and contribute to improved patient outcomes.\n\nFor Round 14\, applicants with projects that address the following NSW Health Research and Innovation Strategy aligned priorities are encouraged to apply: \n\nWomen’s Health\nFemale Entrepreneurs\nAboriginal Health\n\nApplicants with projects that do not address the above priorities are also able to apply. \n\nThe program funds project activities used for any purpose that meets the objectives of the program\, subject to the exclusions below. \nExamples of activities that can be funded include: \n\n\n\ndevice development\, including proof-of-concept\, prototyping\, and piloting studies\n\n\n\n\nmanufacturing samples for product trials\n\n\n\n\nclinical assessment\n\n\n\n\nlocating other national and international trials and research relevant to the product under development\n\n\n\n\nbusiness planning\, including conducting market and product assessments\n\n\n\n\nintellectual property management\n\n\n\n\ncommercialisation\n\n\n\n\ncapital raising\n\n\n\n\nKey Dates:\nPreliminary applications close: 9 June 2026\, 5:00pm AEST\nFull applications for this grant are by invitation only.\nNotification of final outcomes: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nswhealth-medical-devices-fund/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/NSW-Medical-Devices-Fund-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260617T170000
DTEND;TZID=Australia/Sydney:20260617T170000
DTSTAMP:20260610T084508
CREATED:20260602T044023Z
LAST-MODIFIED:20260603T011355Z
UID:10000301-1781715600-1781715600@melanoma.org.au
SUMMARY:SHP Annual Awards
DESCRIPTION:Sydney Health Partners Awards celebrate outstanding early career researchers\, clinician researchers\, and consumers who are creating lasting impact in clinical and health services research. Award winners will be announced at the upcoming SHP Annual Forum on 29 July 2026. \n\n\n\n\n\nAward Categories\n \n\n\n\n\nEarly career researchers and clinician researchers can apply or be nominated for one of five Awards: \n\nTranslational Research Addressing a Health Priority\nClinical Trial Excellence\nExcellence in Consumer-Researcher Partnerships\nResearcher–Health Professional Collaborations\nSHP Using Research to Change Health Practice\n\nEach Award winner will receive funding of $2\,000 for: \n\nresearch-related professional development expenses\, and/or\npayments for consumers partnering in research.\n\nNominees for the early career researchers and clinician researcher awards must be employed by a Sydney Health Partner organisation.  \n\nConsumer Contributions to Health Research\n\nThis consumer-focused award recognises the valued contribution of consumers who are actively involved in shaping health research that matters. Consumers can either self-nominate or be nominated by others. \nThe Consumer Award includes a gift card to the value of $250. \nAll nominations must include endorsement from a senior manager or researcher employed by a Sydney Health Partner organisation.  \n\n\n\n\n\n\n\n\nNominate Now:\n\n\n\n\nNominations for the 2026 SHP Awards are now open and will close at 5:00pm AEST on Wednesday\, 17th June 2026. \n\n\n\n\nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/shp-annual-awards/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/Sydney-Health-Partners-Annual-Awards-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260703T170000
DTEND;TZID=Australia/Sydney:20260703T170000
DTSTAMP:20260610T084508
CREATED:20260602T044844Z
LAST-MODIFIED:20260602T044906Z
UID:10000305-1783098000-1783098000@melanoma.org.au
SUMMARY:SHP Pilot Grants
DESCRIPTION:SHP Pilot Grants – Funding to Test and Implement Research Into Clinical Practice \nEach year\, Sydney Health Partners funds pilot projects that help clinicians\, researchers and health professionals turn evidence into practical healthcare solutions and scale up the implementation of research for broader impact. \nIf you’re a health professional\, clinician\, or researcher leading research within Sydney Health Partners’ affiliated health services\, a Pilot Grant could help you to: \n\nTest real-world implementation of research innovations\nSolve complex health system challenges with practical solutions\nStrengthen applications for major funding bodies (NHMRC\, MRFF\, TRGS)\n\nApplications are now open for Sydney Health Partners 2026 Implementation Science Pilot Grants. \nSydney Health Partners are offering up to $220\,000 in grants to support up to 11 pilot projects\, with two of the projects to be funded by the Charles Perkins Centre Implementation Hub through the Jennie Mackenzie Research Fund. \nGrant Categories: \nStream 1: SHP Implementation Science Pilot Grants (up to 9) \nThese grants require two Principal Investigators (PIs):   \n\nOne from the University of Sydney or an SHP Partner Medical Research Institute (MRI)\n\n\nOne from an SHP Health Service Partner\n\nStream 2: CPC Implementation Hub Pilot Grants (x2) \nThese grants require two PIs – One must be a member of the Charles Perkins Centre: \n\nOne must be a University of Sydney or SHP Partner MRI employee\n\n\nOne from an SHP Health Service Partner\n\n\nKey Dates:\nApplications close: 3 July 2026\, 5:00pm AEST\nSuccessful applicants will be notified: August 2026\nGrants will commence: from January 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/shp-pilot-grants/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/SHP-Pilot-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260707T170000
DTEND;TZID=Australia/Sydney:20260707T170000
DTSTAMP:20260610T084508
CREATED:20260505T055547Z
LAST-MODIFIED:20260505T055547Z
UID:10000290-1783443600-1783443600@melanoma.org.au
SUMMARY:RACP Research Awards and Career Grants
DESCRIPTION:Through the RACP Foundation\, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships\, scholarships and grants are available annually\, totalling over $2.5 million in funding. \nCareer Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships. \nResearch Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career. \nResearch Entry Scholarships provide stipend support only and are to assist Fellows and Advanced Trainees who are: \n\nat the start of their research careers and about to enrol in a Masters\, PhD or equivalent research higher degree\nin the 1st or 2nd full-time equivalent year of their research degree.\n\n\nKey Dates\nApplications close: 30 June 2026\nApplications close (Research Entry Scholarships): 7 July 2026\nOutcomes advised: December 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/racp-awards-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/RACP-Awards-and-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260610T084508
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260610T084508
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260729T170000
DTEND;TZID=Australia/Sydney:20260729T170000
DTSTAMP:20260610T084508
CREATED:20260602T051412Z
LAST-MODIFIED:20260603T013901Z
UID:10000299-1785344400-1785344400@melanoma.org.au
SUMMARY:NHMRC Investigator Grants
DESCRIPTION:Investigator Grants provide the highest-performing researchers at all career stages with consolidated funding for their salary (if required) and a significant research support package. \nIn this way\, the Chief Investigator has flexibility to pursue important new research directions as they arise\, adjust their resources accordingly\, and to form collaborations as needed\, rather than being restricted to the scope of a specific research project. \nInvestigator Grants support: \n\nResearch across the 4 pillars of health and medical research: biomedical\, clinical\, public health and health services research.\nAll career stages: early career researchers\, mid-career researchers and established researchers\nResearchers with clinical responsibilities (such as clinicians\, public health and allied health practitioners)\nFull-time and part-time researchers.\n\nInvestigator Grants aim to: \n\nAllow flexibility for investigators to pursue important new research directions as they arise and to form collaborations as needed\nFoster innovative and creative research\nCreate opportunities for researchers at all career stages to establish their own research programs\nReduce application and peer review burden on researchers.\n\n\nKey Dates:\nApplications open: 3 June 2026\nMinimum data due: 1 July 2026\nApplications close: 29 July 2026\nProposed peer review: August – November 2026\nOutcomes to be advised: March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-investigator-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/NHMRC-Investigator-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260610T084508
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260610T084508
CREATED:20260602T045536Z
LAST-MODIFIED:20260602T045536Z
UID:10000303-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
DESCRIPTION:The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers. \nThe objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nStream 1 (Incubator): conduct early stage\, small scale research\, led by early career researchers\, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.\nStream 2 (Accelerator): establish a large-scale interdisciplinary research program\, led by mid-career researchers\, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.\nStream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).\n\nThe intended outcome of the research is to improve the health and wellbeing of Australians by: \n\nStream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.\nStream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.\nStream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.\n\n\nKey Dates:\nMinimum data due: 22 July 2026\nApplications close: 19 August 2026\nGrant activity timeframe: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-emcr-initiative/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-EMCR-Initiative-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260916T170000
DTEND;TZID=Australia/Sydney:20260916T170000
DTSTAMP:20260610T084508
CREATED:20260602T045957Z
LAST-MODIFIED:20260602T045957Z
UID:10000300-1789578000-1789578000@melanoma.org.au
SUMMARY:MRFF International Clinical Trial Collaborations
DESCRIPTION:The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nPromote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.\nProvide high-quality evidence of the effectiveness of novel health treatments\, drugs or devices in ‘usual care’ settings\, which will support a decision on whether to deliver the intervention in an Australian setting.\n\nThe anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nPlease note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. \n\nKey Dates:\nMinimum data due: 19 August 2026\nApplications close: 16 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-int-clinical-trial-collaborations/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-International-Clinical-Trial-Collaborations-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261014T170000
DTEND;TZID=America/Halifax:20261014T170000
DTSTAMP:20260610T084508
CREATED:20260602T051105Z
LAST-MODIFIED:20260602T051105Z
UID:10000302-1791997200-1791997200@melanoma.org.au
SUMMARY:CDMRP Melanoma Research Program
DESCRIPTION:The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: \n\n\n\n·        Focused Program Award – Rare Melanomas  \nThis award supports a multidisciplinary research program of at least two\, but not more than three\, distinct but complementary research projects addressing an overarching question relevant to rare melanomas. \n·        Idea Award \nThe Idea Award supports innovative\, exploratory\, high-risk/potentially high-reward research. Novelty and innovation are expected to be key aspects of the proposed project. By the end of the Idea Award funding period\, the anticipated outcomes of successful efforts should establish proof of principle and obtain preliminary data to secure follow-on funding. \n·        Melanoma Academy Scholar Award \nSupports the addition of independent\, early career investigators (Scholars) who are no more than seven years from their initial faculty appointment to the Melanoma Research Program (MRP) Melanoma Academy. The Melanoma Academy is a unique\, interactive virtual academy focused on bringing together established investigators and Scholars to develop a network of successful\, highly productive melanoma researchers in a collaborative research and career development environment. \n·        Survivorship Research Award \nThe award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors\, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life\, overall health and/or function are not responsive to this funding opportunity. \n·        Team Science Award \nSupports a broad range of hypothesis-driven\, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques\, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex\, multi-dimensional problems that will impact patient outcomes. \nKey Dates: \nSubmission Deadline (Pre-application-Pre-Proposal): 13 July 2026\nFocused Program Award – Rare Melanomas\nIdea Award\nTeam Science Award \nSubmission Deadline (Pre-application-Pre-Proposal): 22 September 2026\nMelanoma Academy Scholar Award\nSurvivorship Research Award \nApplication Submission Deadline: 14 October 2026 \n\n\n\n\n\n\n\n\n\nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/cdmrp-melanoma-program/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/CDMRP-Research-Program-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260610T084508
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR